Literature DB >> 16428751

The Bordetella bronchiseptica type III secretion system inhibits gamma interferon production that is required for efficient antibody-mediated bacterial clearance.

Mylisa R Pilione1, Eric T Harvill.   

Abstract

Several species of pathogenic microorganisms have developed strategies to survive and persist in vital organs which are normally maintained as sterile by the generation of strong immune responses. Here, we report an immunomodulation involving the Bordetella bronchiseptica type III secretion system (TTSS) which contributes to bacterial survival in the lower respiratory tract of the host. The prolonged persistence of B. bronchiseptica that was observed in gamma interferon (IFN-gamma)-/- mice indicates that the efficient clearance of bacteria from the lower respiratory tract requires not only B cells and antibodies but also IFN-gamma production. Our data also suggest that interleukin-10 (IL-10)-producing splenocytes are generated early during infection and that IL-10 inhibits IFN-gamma-producing cells and delays the clearance of B. bronchiseptica from the lungs. The TTSS of B. bronchiseptica inhibits the generation of IFN-gamma-producing splenocytes and is required for long-term bacterial persistence in the lower respiratory tract in wild-type mice. This suggests that a mechanism involving the modulation of IFN-gamma production by the TTSS facilitates B. bronchiseptica survival in the lower respiratory tract.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16428751      PMCID: PMC1360352          DOI: 10.1128/IAI.74.2.1043-1049.2006

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  30 in total

Review 1.  Mechanisms of Bordetella pathogenesis.

Authors:  S Mattoo; A K Foreman-Wykert; P A Cotter; J F Miller
Journal:  Front Biosci       Date:  2001-11-01

2.  CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity.

Authors:  Yasmine Belkaid; Ciriaco A Piccirillo; Susana Mendez; Ethan M Shevach; David L Sacks
Journal:  Nature       Date:  2002-12-05       Impact factor: 49.962

3.  Bordetella bronchiseptica PagP is a Bvg-regulated lipid A palmitoyl transferase that is required for persistent colonization of the mouse respiratory tract.

Authors:  Andrew Preston; Elizabeth Maxim; Elinor Toland; E Jane Pishko; Eric T Harvill; Martine Caroff; Duncan J Maskell
Journal:  Mol Microbiol       Date:  2003-05       Impact factor: 3.501

4.  Pregenomic comparative analysis between bordetella bronchiseptica RB50 and Bordetella pertussis tohama I in murine models of respiratory tract infection.

Authors:  E T Harvill; P A Cotter; J F Miller
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

5.  IL-10-producing T cells suppress immune responses in anergic tuberculosis patients.

Authors:  V A Boussiotis; E Y Tsai; E J Yunis; S Thim; J C Delgado; C C Dascher; A Berezovskaya; D Rousset; J M Reynes; A E Goldfeld
Journal:  J Clin Invest       Date:  2000-05       Impact factor: 14.808

6.  Multiple roles for Bordetella lipopolysaccharide molecules during respiratory tract infection.

Authors:  E T Harvill; A Preston; P A Cotter; A G Allen; D J Maskell; J F Miller
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

7.  Role of Bordetella O antigen in respiratory tract infection.

Authors:  Valorie C Burns; Elizabeth J Pishko; Andrew Preston; Duncan J Maskell; Eric T Harvill
Journal:  Infect Immun       Date:  2003-01       Impact factor: 3.441

8.  The microbicidal activity of interferon-gamma-treated macrophages against Trypanosoma cruzi involves an L-arginine-dependent, nitrogen oxide-mediated mechanism inhibitable by interleukin-10 and transforming growth factor-beta.

Authors:  R T Gazzinelli; I P Oswald; S Hieny; S L James; A Sher
Journal:  Eur J Immunol       Date:  1992-10       Impact factor: 5.532

9.  Role of antibodies in immunity to Bordetella infections.

Authors:  Girish S Kirimanjeswara; Paul B Mann; Eric T Harvill
Journal:  Infect Immun       Date:  2003-04       Impact factor: 3.441

10.  Pathogen-specific T regulatory 1 cells induced in the respiratory tract by a bacterial molecule that stimulates interleukin 10 production by dendritic cells: a novel strategy for evasion of protective T helper type 1 responses by Bordetella pertussis.

Authors:  Peter McGuirk; Chantelle McCann; Kingston H G Mills
Journal:  J Exp Med       Date:  2002-01-21       Impact factor: 14.307

View more
  41 in total

1.  Interleukin-1 receptor signaling is required to overcome the effects of pertussis toxin and for efficient infection- or vaccination-induced immunity against Bordetella pertussis.

Authors:  Xuqing Zhang; Sara E Hester; Mary J Kennett; Alexia T Karanikas; Liron Bendor; David E Place; Eric T Harvill
Journal:  Infect Immun       Date:  2010-10-25       Impact factor: 3.441

2.  Use of a genetically defined double mutant strain of Bordetella bronchiseptica lacking adenylate cyclase and type III secretion as a live vaccine.

Authors:  Paul Mann; Elizabeth Goebel; James Barbarich; Mylisa Pilione; Mary Kennett; Eric Harvill
Journal:  Infect Immun       Date:  2007-04-23       Impact factor: 3.441

3.  Constraint-based network model of pathogen-immune system interactions.

Authors:  Juilee Thakar; Assieh Saadatpour-Moghaddam; Eric T Harvill; Réka Albert
Journal:  J R Soc Interface       Date:  2008-10-24       Impact factor: 4.118

4.  Snapshot of spatio-temporal cytokine responses to single and co-infections with helminths and bacteria.

Authors:  Ashutosh K Pathak; Michael C Biarnes; Lisa Murphy; Isabella M Cattadori
Journal:  Results Immunol       Date:  2011-11-04

5.  Role of the type III secretion system in a hypervirulent lineage of Bordetella bronchiseptica.

Authors:  Anne M Buboltz; Tracy L Nicholson; Laura S Weyrich; Eric T Harvill
Journal:  Infect Immun       Date:  2009-07-13       Impact factor: 3.441

Review 6.  Virulence factor secretion and translocation by Bordetella species.

Authors:  Ruchi Shrivastava; Jeff F Miller
Journal:  Curr Opin Microbiol       Date:  2009-01-29       Impact factor: 7.934

7.  O antigen allows B. parapertussis to evade B. pertussis vaccine-induced immunity by blocking binding and functions of cross-reactive antibodies.

Authors:  Xuqing Zhang; Maria Eugenia Rodríguez; Eric T Harvill
Journal:  PLoS One       Date:  2009-09-14       Impact factor: 3.240

8.  The Bordetella bronchiseptica type III secretion system is required for persistence and disease severity but not transmission in swine.

Authors:  Tracy L Nicholson; Susan L Brockmeier; Crystal L Loving; Karen B Register; Marcus E Kehrli; Sarah M Shore
Journal:  Infect Immun       Date:  2013-12-23       Impact factor: 3.441

9.  Bordetella evades the host immune system by inducing IL-10 through a type III effector, BopN.

Authors:  Kanna Nagamatsu; Asaomi Kuwae; Tadashi Konaka; Shigenori Nagai; Sei Yoshida; Masahiro Eguchi; Mineo Watanabe; Hitomi Mimuro; Shigeo Koyasu; Akio Abe
Journal:  J Exp Med       Date:  2009-12-14       Impact factor: 14.307

10.  The Bordetella type III secretion system effector BteA contains a conserved N-terminal motif that guides bacterial virulence factors to lipid rafts.

Authors:  Christopher T French; Ekaterina M Panina; Sylvia H Yeh; Natasha Griffith; Diego G Arambula; Jeff F Miller
Journal:  Cell Microbiol       Date:  2009-07-24       Impact factor: 3.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.